Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis.

Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis.

Detalles Bibliográficos
Main Authors:	Robbins, P, Tahara, H, Mueller, G, Hung, G, Bahnson, A, Zitvogel, L, Galea-Lauri, J, Ohashi, T, Patrene, K, Boggs, S
Formato:	Journal article
Idioma:	English
Publicado:	1994

Títulos similares

Affinity mediated magnetic concentration of retroviral vectors
por: Hughes, C, et al.
Publicado: (2001)

A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy.
por: Kuiper, M, et al.
Publicado: (1996)

Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre.
por: Darling, D, et al.
Publicado: (2000)

Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy
por: Luca Biasco, et al.
Publicado: (2018-03-01)

Q Vectors, Bicistronic Retroviral Vectors for Gene Transfer
por: Martin A. Julius, et al.
Publicado: (2000-04-01)

Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.
por: Hughes, C, et al.
Publicado: (2001)

Gene expression studies using retroviral vectors
por: Cone, Roger David.
Publicado: (2024)

Enhanced gene expression from retroviral vectors
por: Micklem David R, et al.
Publicado: (2008-02-01)

Retroviral Gene Vectors Show Clear Target Preferences.
Publicado: (2004-12-01)

Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo.
por: Nita, I, et al.
Publicado: (1996)

An XMRV Derived Retroviral Vector as a Tool for Gene Transfer
por: Rojas-Martinez Augusto, et al.
Publicado: (2011-06-01)

Therapy of adult Gaucher disease
por: Joerg Schmitz, et al.
Publicado: (2007-02-01)

Optimal therapy in Gaucher disease
por: Ozlem Goker-Alpan
Publicado: (2010-07-01)

Gaucher Disease and Gaucher Cells
por: Sevgi Gözdaşoğlu
Publicado: (2015-05-01)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
por: Inès Dufait, et al.
Publicado: (2012-01-01)

Restriction Mapping of Retroviral Vector Episomal DNA
por: Won-Bin Young, et al.
Publicado: (2000-03-01)

Retroviral Vectors for Analysis of Viral Mutagenesis and Recombination
por: Jonathan M.O. Rawson, et al.
Publicado: (2014-09-01)

A method to estimate the efficiency of gene expression from an integrated retroviral vector
por: Lever Andrew, et al.
Publicado: (2006-08-01)

Retroviral integration profiles: their determinants and implications for gene therapy
por: Kwang-il Lim
Publicado: (2012-04-01)

GAUCHER’S DISEASE
por: O. S. Gundobina, et al.
Publicado: (2013-11-01)

Gaucher Cells or Pseudo-Gaucher Cells: That's the Question
por: Deniz Gören Şahin, et al.
Publicado: (2014-12-01)

Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors.
por: Alessandro Ambrosi, et al.
Publicado: (2011-12-01)

Retroviral Vectors: Post Entry Events and Genomic Alterations
por: Christof von Kalle, et al.
Publicado: (2011-04-01)

Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
por: Utpal P Davé, et al.
Publicado: (2009-05-01)

Gaucher disease.
por: Butters, T
Publicado: (2007)

Gaucher Disease
por: Guilherme Henrique Hencklain Fonseca, et al.
Publicado: (2007-03-01)

Gaucher′s disease
por: Vijay Bohra, et al.
Publicado: (2011-01-01)

Efficient Expression of Exogenous Genes in Primary Vascular Cells Using IRES-Based Retroviral Vectors
por: Kyle J. Garton, et al.
Publicado: (2002-04-01)

Integrating Retroviral Cassette Extends Gene Delivery of HSV-1 Expression Vectors to Dividing Cells
por: Pablo de Felipe, et al.
Publicado: (2001-08-01)

Splenic lipids in Gaucher's disease
por: N.G. Kennaway, et al.
Publicado: (1968-11-01)

An Overview of Gaucher Disease
por: Daniela Anahí Méndez-Cobián, et al.
Publicado: (2024-12-01)

Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium.
por: Hung, G, et al.
Publicado: (1994)

Insertional mutagenesis in zebrafish using a pseudotyped retroviral vector
por: Gaiano, Nicholas R. (Nicholas Roger)
Publicado: (2008)

A new generation of pPRIG-based retroviral vectors
por: Boulukos Kim E, et al.
Publicado: (2007-11-01)

Understanding patient and parent/caregiver perceptions on gene therapy in Gaucher disease: an international survey
por: Tanya Collin-Histed, et al.
Publicado: (2023-01-01)

Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
por: Kristine E. Yoder, et al.
Publicado: (2021-05-01)

Imino sugar therapy for type 1 Gaucher disease.
por: Priestman, D, et al.
Publicado: (2000)

An efficient large-scale retroviral transduction method involving preloading the vector into a RetroNectin-coated bag with low-temperature shaking.
por: Katsuyuki Dodo, et al.
Publicado: (2014-01-01)

Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy
por: Marieke Griffioen, et al.
Publicado: (2009-09-01)

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer.
por: Bandara, G, et al.
Publicado: (1993)